LNDZF OTC
Evome Medical Technologies Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -97.6%
3Y: -100.0%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$63M
+0.0% ▲
5Y CAGR: +73.9%
Gross Profit
$23M
+0.0% ▲
Operating Income
-$6M
+0.0% ▲
Net Income
-$16M
+0.0% ▲
EPS (Diluted)
$-0.16
+0.0% ▲
EBITDA
-$10M
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $3M | $352K | -$34K | $18M | $63M |
| YoY Growth | -20.1% | -88.8% | -109.5% | +54686.9% | +0.0% |
| Cost of Revenue | $62K | $372K | $12M | $12M | $40M |
| Gross Profit | $3M | -$20K | -$12M | $6M | $23M |
| Gross Margin | 98.0% | -5.8% | 36914.6% | 32.6% | 36.0% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4M | $2M | $990K | $6M | $24M |
| Operating Expenses | $4M | $2M | $990K | $6M | $28M |
| Operating Income | -$761K | -$2M | -$1M | -$5M | -$6M |
| Operating Margin | -24.2% | -479.5% | 3051.9% | -26.4% | -8.8% |
| Interest Expense | $0 | $0 | $388K | $388K | $3M |
| Income Before Tax | -$761K | -$2M | -$3M | -$4M | -$16M |
| Tax Expense | $0 | $613K | $0 | -$102K | $57K |
| Net Income | -$761K | -$2M | -$3M | -$4M | -$16M |
| Net Margin | -24.2% | -664.9% | 7951.3% | -23.9% | -24.9% |
| EPS (Diluted) | $-0.02 | $-0.07 | $-0.06 | $-0.10 | $-0.16 |
| EBITDA | -$505K | -$2M | -$1M | -$3M | -$10M |
| Shares Outstanding | 34M | 34M | 44M | 44M | 73M |